[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"current-user-roles":3,"user-subscription":3,"bill:119-s-2292":4},null,{"bill":5,"indexable":135,"summaries":136,"cosponsors":142,"cosponsorSlugs":157,"actions":161,"amendments":200,"amendmentSponsorSlugs":201,"linkages":202,"sponsorSlug":203},{"statusDate":6,"sponsor":7,"cboCostEstimates":14,"originChamber":15,"congress":16,"isByRequest":17,"title":18,"createdAt":19,"committeeReports":20,"cosponsorCount":21,"onBehalfOfSponsor":3,"adminOverride":3,"amendmentCount":22,"actionCount":23,"popularTitle":3,"laws":3,"billType":24,"introducedDate":25,"committees":26,"congressGovUrl":27,"constitutionalAuthority":3,"policyArea":28,"deletedAt":3,"latestAction":29,"billNumber":31,"cosponsorCountIncludingWithdrawn":21,"status":32,"keyMilestoneCount":21,"subjects":33,"policyAreaLower":38,"updateDate":39,"shortTitle":18,"officialTitle":40,"updatedAt":41,"searchTokens":42,"committeeCodes":134},"2025-09-08",{"firstName":8,"lastName":9,"fullName":10,"state":11,"party":12,"bioguideId":13},"Jim","Banks","Sen. Banks, Jim [R-IN]","IN","R","B001299",[],"Senate",119,false,"Over-the-Counter Monograph Drug User Fee Amendments","2026-05-11T19:06:19.872Z",[],3,0,6,"s","2025-07-15",[],"https:\u002F\u002Fwww.congress.gov\u002Fbill\u002F119th-congress\u002Fsenate-bill\u002F2292","Health",{"date":6,"text":30},"Placed on Senate Legislative Calendar under General Orders. Calendar No. 152.",2292,"reported",[34,35,36,37],"Congressional oversight","Drug safety, medical device, and laboratory regulation","Supply chain","User charges and fees","health","2026-06-03T21:04:50Z","A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes.","2026-06-04T02:15:35.294Z",[43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133],"over","ov","ove","the","counter","co","cou","coun","count","counte","monograph","mo","mon","mono","monog","monogr","monogra","monograp","drug","dr","dru","user","us","use","fee","amendments","am","ame","amen","amend","amendm","amendme","amendmen","amendment","bill","bi","bil","to","federal","fe","fed","fede","feder","federa","food","fo","foo","and","cosmetic","cos","cosm","cosme","cosmet","cosmeti","act","revise","re","rev","revi","revis","extend","ex","ext","exte","exten","program","pr","pro","prog","progr","progra","for","drugs","other","ot","oth","othe","purposes","pu","pur","purp","purpo","purpos","purpose","sen","banks","ba","ban","bank","jim","in",[],true,[137],{"versionCode":138,"actionDate":6,"actionDesc":139,"text":140,"updateDate":141},"25","Reported to Senate","\u003Cp>\u003Cstrong>Over-the-Counter Monograph Drug User Fee Amendments\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>This bill reauthorizes the Over-the-Counter (OTC) Monograph Drug User Fee Program (OMUFA); revises procedures used by the Food and Drug Administration (FDA) to evaluate topical, nonprescription drugs (e.g., sunscreens); and requires the FDA to clarify the process through which a prescription drug may be switched to nonprescription status.\u003C\u002Fp>\u003Cp>Under current law, many OTC drugs are marketed through compliance with an OTC monograph issued by the FDA, rather than through an approved new drug application. Monographs establish the conditions under which OTC drugs are generally recognized as safe and effective. The bill reauthorizes the collection of OMUFA fees from OTC drug facilities through FY2030 and revises methods for calculating such fees.\u003C\u002Fp>\u003Cp>Separately, the bill requires the FDA to allow for the use of real-world evidence to demonstrate the safety and effectiveness of active ingredients in topical, nonprescription drugs. The FDA must consider nonclinical tests and other alternatives to animal testing in evaluating such drugs.\u003C\u002Fp>\u003Cp>The FDA must also issue guidance to clarify the application process for nonprescription drugs, including applications to switch a prescription drug to nonprescription status. The FDA must plan to engage stakeholders in identifying drugs that are promising candidates for a switch. Moreover, applicants seeking a switch may request to meet with the FDA to develop a plan for the requisite application.\u003C\u002Fp>\u003Cp>Finally, the Government Accountability Office must report on (1) the OTC monograph drug supply chain, and (2) the FDA’s handling of applications to switch a prescription drug to nonprescription status.\u003C\u002Fp>","2026-06-03T21:03:38Z",[143,149,153],{"bioguideId":144,"fullName":145,"party":146,"state":147,"sponsorshipDate":148,"isOriginalCosponsor":17,"withdrawn":17,"sponsorshipWithdrawnDate":3},"K000394","Sen. Kim, Andy [D-NJ]","D","NJ","2025-07-29",{"bioguideId":150,"fullName":151,"party":12,"state":152,"sponsorshipDate":148,"isOriginalCosponsor":17,"withdrawn":17,"sponsorshipWithdrawnDate":3},"H001104","Sen. Husted, Jon [R-OH]","OH",{"bioguideId":154,"fullName":155,"party":146,"state":156,"sponsorshipDate":25,"isOriginalCosponsor":135,"withdrawn":17,"sponsorshipWithdrawnDate":3},"K000384","Sen. Kaine, Tim [D-VA]","VA",{"K000394":158,"H001104":159,"K000384":160},"andy-kim","jon-husted","tim-kaine",[162,165,177,182,188,195],{"actionDate":6,"actionDateTime":3,"text":30,"type":163,"actionCode":3,"sourceSystem":164,"committees":3,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":22,"isKeyMilestone":17},"Calendars",{"name":15},{"actionDate":6,"actionDateTime":3,"text":166,"type":167,"actionCode":168,"sourceSystem":169,"committees":172,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":176,"isKeyMilestone":135},"Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.","Committee","14000",{"code":170,"name":171},9,"Library of Congress",[173],{"name":174,"systemCode":175},"Health, Education, Labor, and Pensions Committee","sshr00",2,{"actionDate":6,"actionDateTime":3,"text":166,"type":167,"actionCode":3,"sourceSystem":178,"committees":179,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":181,"isKeyMilestone":135},{"name":15},[180],{"name":174,"systemCode":175},1,{"actionDate":183,"actionDateTime":3,"text":184,"type":167,"actionCode":3,"sourceSystem":185,"committees":186,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":21,"isKeyMilestone":17},"2025-07-30","Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.",{"name":15},[187],{"name":174,"systemCode":175},{"actionDate":25,"actionDateTime":3,"text":189,"type":190,"actionCode":3,"sourceSystem":191,"committees":192,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":194,"isKeyMilestone":17},"Read twice and referred to the Committee on Health, Education, Labor, and Pensions.","IntroReferral",{"name":15},[193],{"name":174,"systemCode":175},4,{"actionDate":25,"actionDateTime":3,"text":196,"type":190,"actionCode":197,"sourceSystem":198,"committees":3,"recordedVotes":3,"calendarNumber":3,"sequenceIndex":199,"isKeyMilestone":135},"Introduced in Senate","10000",{"code":170,"name":171},5,[],{},[],"jim-banks"]